Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Impact of Residual Disease as a Prognostic Factor for Survival in Women With Advanced Epithelial Ovarian Cancer After Primary Surgery." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery.
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery. Accessed February 12, 2025.
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery
Impact of Residual Disease as a Prognostic Factor for Survival in Women With Advanced Epithelial Ovarian Cancer After Primary Surgery [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
ID - 432048
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432048/all/Impact_of_residual_disease_as_a_prognostic_factor_for_survival_in_women_with_advanced_epithelial_ovarian_cancer_after_primary_surgery
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -